Symbols

PGNY

Progyny·NASDAQ

--(--)

PGNY fundamentals

PGNY Q4 2025 Earnings

Progyny (PGNY) released its earnings on Feb 26, 2026: revenue was 318.40M (YoY +6.69%), beat estimates; EPS was 0.14 (YoY +16.67%), missed estimates.

Revenue / YoY

318.40M

+6.69%

EPS / YoY

0.14

+16.67%

Report date

Feb 26, 2026

PGNY Earnings Call Summary for Q4,2025

Record 2025 Performance: $1.29B revenue (+10%), $222M EBITDA (+13%), 100% client retention.
New Services Expansion: 2.7M members access postpartum/menopause care; 30% clients upsold benefits.
Progyny Select Launch: Targets 50M lives in fully insured plans, expected to contribute from 2027.
2026 Guidance: $1.355B-$1.405B revenue (5.1%-9% growth), $224M-$239M EBITDA.
Cost Efficiency: Stock-based comp to drop 35% YoY; 75% EBITDA-to-cash conversion rate.
Strong Cash Position: $310M cash, no debt, $84M share buybacks in Q4.

Earnings

EPS

Revenue

Revenue & Expenses

PGNY has released its 2025 Q4 earnings report, with revenue of 318.40M, reflecting a YoY change of 6.69%, and net profit of 12.48M, showing a YoY change of 18.54%. The Sankey diagram below clearly presents PGNY's revenue sources and cost distribution.

Key Indicators

Progyny (PGNY) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

Progyny (PGNY)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.

Trend

Breakdown

Balance Sheet

Progyny (PGNY)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.

Trend

Breakdown

Cash Flow

Progyny (PGNY)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.

Trend

Breakdown